Lataa...
The influence of ketamine on drug discovery in depression
Recent research demonstrating that the glutamatergic modulator ketamine has rapid, robust and sustained antidepressant effects has been a turning point in drug discovery for depression. The recent FDA approval of esketamine for adults with treatment-resistant major depressive disorder (MDD) has furt...
Tallennettuna:
| Julkaisussa: | Drug Discov Today |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6842425/ https://ncbi.nlm.nih.gov/pubmed/31382015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2019.07.007 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|